A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/165 (2006.01) A61P 25/00 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2675244
Methods for treating cognitive dysfunction associated with fibromyalgia by administering high-dose milnacipran to a patient suffering from such cognitive dysfunction are provided. Also provided are methods for the long-term treatment of cognitive dysfunction associate with FMS by administering milnacipran to a patient suffering from such cognitive dysfunction.
L'invention concerne des procédés de traitement du dysfonctionnement cognitif associé à la fibromyalgie par administration de milnacipran à forte dose à un patient souffrant d'un tel dysfonctionnement cognitif. L'invention concerne également des procédés de traitement à long terme du dysfonctionnement cognitif associé à la FMS par administration de milnacipran à un patient souffrant d'un tel dysfonctionnement cognitif.
Gendreau Michael R.
Kranzler Jay D.
Rao Srinivas G.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Cypress Bioscience Inc.
LandOfFree
Milnacipran for the treatment of cognitive dysfunction... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Milnacipran for the treatment of cognitive dysfunction..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Milnacipran for the treatment of cognitive dysfunction... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1619062